Delaware health officials have officially declared a measles outbreak following the confirmation of four cases within the state. The Delaware Division of Public Health (DPH) announced on July 22, 2026, that two additional cases had been identified, reaching the threshold required to categorize the situation as an outbreak. According to the Centers for Disease Control and Prevention (CDC), a measles outbreak is defined as three or more cases connected by time and location.
Delaware Confirms Measles Outbreak
All four confirmed cases involve unvaccinated adult men residing in Kent County, according to the WBOC. These represent the first confirmed cases of the virus in Delaware in over a decade. Dr. Robert Rosenbaum, medical director of the Delaware EMS and Preparedness section, stated that officials are currently working to determine how the patients contracted the airborne virus.
Contact Tracing and Public Health Response
In response to the rising case count, the DPH has initiated extensive contact tracing to identify individuals who may have been exposed to the virus. Authorities are notifying identified contacts to determine their vaccination status, provide educational resources, and recommend medical treatment when necessary.

Health officials have indicated that if contact tracing reveals any known public exposures, additional information will be released to the public. Due to medical privacy restrictions, the DPH has stated it is currently unable to provide further details regarding the specific individuals who tested positive.
Understanding Risks and Symptoms
Measles is a highly contagious, acute viral illness that spreads through infectious droplets. The virus can remain in the air or on surfaces for up to two hours after an infected person has left a location.
Early symptoms typically include:
- Fever
- Cough
- Runny nose (coryza)
- Pink eye (conjunctivitis)
A rash usually appears three to five days after the onset of these initial symptoms, typically beginning on the face before spreading down the body. The Delaware government notes that the virus can lead to severe health complications, including pneumonia, brain inflammation, and death. Groups at the highest risk for severe complications include those who are unvaccinated, pregnant, immunocompromised, or children who are too young to be vaccinated.
Vaccination and Immunity Guidelines
The MMR vaccine is the primary defense against the virus and is 97% effective at preventing measles for those who have received two doses and are not severely immunocompromised.

According to state health guidelines, individuals are generally considered immune if they:
- Were born before 1957.
- Have received a laboratory test confirming they previously had measles.
- Have received a laboratory test confirming immunity to measles.
- Have received two doses of a measles-containing vaccine, such as the MMR vaccine.
Children are generally expected to receive their first dose between 12 and 15 months of age and their second dose between 4 and 6 years of age. The DPH encourages residents to review their vaccination records through the DelVAX Public Portal or by consulting a primary care provider. For those who are unvaccinated or unsure of their status, officials recommend contacting a healthcare provider or public health clinic to discuss receiving the vaccine.
Guidance for Residents and Providers
Anyone experiencing symptoms associated with measles is advised to contact a healthcare provider before arriving at a medical facility to ensure proper precautions are taken and to prevent further exposure. For those with severe symptoms, officials recommend seeking immediate emergency care.
Providers who identify potential cases are instructed to contact the DPH Office of Infectious Disease Epidemiology (OIDE) at 302-744-4990 during business hours or the state’s 24-hour reporting line at 1-888-295-5156. Further information for the public is available at Coastalpoint and the official state portal at de.gov/measles.
Related reading
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.